GSK plc
The Scientist, Early Formulation will develop fit-for-purpose vaccine formulations to support preclinical studies and generate in vitro assessment insights that guide antigen design and lead selection. This hands-on, laboratory-based role involves designing and executing formulation and stability studies, characterizing physicochemical properties, and generating data to inform portfolio decision-making across multiple vaccine modalities. The position requires collaboration with project teams to ensure timely candidate ranking, selection, and optimization.
Headquarters
London, England, United Kingdom
Company Size
10001+ employees
Founded
1830
At GSK, we unite science, technology and talent to get ahead of disease together
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GSK plc.
Right around the average for this role
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
Dec 19, 2025